101
|
Blain A, Greally E, MacGowan G, Laval S, Blamire A, Gillender K, Lochmüller H, Bushby K, Straub V. P18 Beta-blocker/ACE-inhibitor combination treatment in mdx mice. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70026-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
102
|
Machado P, Hudson J, Miller A, Morrow J, Parton M, Bushby K, Hanna M. P82 Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM). Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70090-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
103
|
Henderson M, Hudson J, Marsh J, Charlton R, Straub V, Lochmüller H, Bushby K, Vissing J, Barresi R. P70 A single in-frame deletion in the CAPN3 gene is linked to muscular dystrophy with a dominant pattern of inheritance. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70078-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
104
|
Hicks D, Martoni E, Straub V, Lochmüller H, Laval S, Bushby K. P79 Identification of novel variants in patients with non-collagen VI Bethlem myopathy by the emerging technology of exomic sequencing. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70087-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
105
|
De Waele L, Henderson M, Hudson J, Horrocks I, Longman C, Bushby K, Barresi R. P77 Autosomal recessive desminopathy with desmin-null mutations presenting in childhood. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70085-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
106
|
Klein A, Lillis S, Oprea I, Scoto M, Robb S, Manzur A, Straub V, Roper H, Jeannet P, Kingston H, Jensen U, Wraige E, Trump N, Rakowicz W, M. Roberts, Longman C, Lochmuller H, Bushby K, Hughes M, Abbs S, Jungbluth H, Muntoni F. P3.41. Clinical and genetic findings in a large cohort of patients with congenital myopathies due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
107
|
Finkel R, Wong B, Bushby K, Voit T, Morsy M, Elfring G, Barth J, Peltz S. P4.10 The relationship of ataluren plasma concentration and response across clinical studies in nonsense mutation dystrophinopathy. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.975] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
108
|
Blain A, Greally E, Laval S, Blamire A, Lochmuller H, Bushby K, MacGowan G, Straub V. P4.17 Manganese enhanced MRI (MEMRI) as an outcome measure for cardiac function in the mdx mouse. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
109
|
Ritso M, Dick E, Reza M, Laval S, Bushby K, Straub V, Denning C, Lochmuller H. P4.36 Develoment of pluripotent stem celss as vectors for viral gene therapy. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.1001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
110
|
Treves S, Jeannet P, Vukcevic M, Levano S, Girard T, Urwyler A, Fischer D, Voit T, Jungbluth H, Lillis S, Muntoni F, Quinlivan R, Sarkozy A, Bushby K, Zorzato F. I-13
Muscle ryanodine receptor in congenital
myopathies and channelopathies. ACTA MYOLOGICA 2011. [PMCID: PMC3235834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
111
|
Mercuri E, Bushby K, McDonald C, Goemans N, Muntoni F, Darras B, Elfring G, Barth J, Reha A, Peltz S. P1.33 Disease progression observed in clinical outcome measures in placebo-treated patients with nonsense mutation dystrophinopathy. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.793] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
112
|
Willis T, Hollingsworth K, Sveen M, Morrow J, Vandenheede J, Strojkovic T, Eagle M, Mayhew A, Bushby K, Lochmuller H, Hanna M, Vissing J, Straub V. P2.22 Quantitative MRI in LGMD2I; a longitudinal study. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
113
|
Gramsch K, Vry J, Rahbek J, Steffensen B, Bushby K, Lochmüller H, Rodger S, Kirschner J. P4.64 Monitoring care practices for Duchenne Muscular Dystrophy – the CARE-NMD project. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.1029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
114
|
Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Jones DH, Longman C, Chow G, Pane M, Main M, Hanna MG, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F. SEPN1-related myopathies: clinical course in a large cohort of patients. Neurology 2011; 76:2073-8. [PMID: 21670436 DOI: 10.1212/wnl.0b013e31821f467c] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To assess the clinical course and genotype-phenotype correlations in patients with selenoprotein-related myopathy (SEPN1-RM) due to selenoprotein N1 gene (SEPN1) mutations for a retrospective cross-sectional study. METHODS Forty-one patients aged 1-60 years were included. Clinical data including scoliosis, respiratory function, and growth measurements were collected by case note review. RESULTS Mean age at onset was 2.7 years, ranging from birth to the second decade of life. All but 2 remained independently ambulant: one lost ambulation at age 5 years and another in his late 50s. The mean age of starting nocturnal noninvasive ventilation (NIV) was 13.9 years. One child required full-time NIV at the age of 1 year while in 2 cases NIV was started at 33 years. Two patients died from respiratory failure at the age of 10 and 22 years, respectively. The mean age at scoliosis onset was 10 years, in most cases preceded by rigidity of the spine. Fourteen patients had successful spinal surgery (mean age 13.9 years). Twenty-one were underweight; however, overt feeding difficulties were not a feature. CONCLUSIONS This study describes the largest population affected by SEPN1-RM reported so far. Our findings show that the spectrum of severity is wider than previously reported. Respiratory insufficiency generally develops by 14 years but may occur as early as in infancy or not until the fourth decade. Motor abilities remain essentially static over time even in patients with early presentation. Most adult patients remain ambulant and fully employed.
Collapse
|
115
|
Willis T, Lochmuller H, Bushby K, Straub V. Dried Blood Spot Testing—The Newcastle Experience Over a Twelve Month Period. Clin Ther 2011. [DOI: 10.1016/j.clinthera.2011.05.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
116
|
Treves S, Vukcevic M, Jeannet PY, Levano S, Girard T, Urwyler A, Fischer D, Voit T, Jungbluth H, Lillis S, Muntoni F, Quinlivan R, Sarkozy A, Bushby K, Zorzato F. Enhanced excitation-coupled Ca2+ entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease. Hum Mol Genet 2011. [DOI: 10.1093/hmg/ddr083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
117
|
Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, Hollingsworth KG, Hunt D, Jungbluth H, Roper HP, Quinlivan RM, Gosalakkal JA, Jayawant S, Nadeau A, Hughes-Carre L, Manzur AY, Mercuri E, Morgan JE, Straub V, Bushby K, Sewry C, Rutherford M, Muntoni F. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011; 76:346-53. [PMID: 21263136 DOI: 10.1212/wnl.0b013e318208811f] [Citation(s) in RCA: 114] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation. METHODS We studied the degree of muscle involvement in the lower leg muscles of 34 patients with DMD >8 years, using muscle MRI. In a subgroup of 15 patients we correlated the muscle MRI findings with the histology of open extensor digitorum brevis (EDB) muscle biopsies. Muscle MRI involvement was assigned using a scale 0-4 (normal-severe). RESULTS In all patients we documented a gradient of involvement of the lower leg muscles: the posterior compartment (gastrocnemius > soleus) was most severely affected; the anterior compartment (tibialis anterior/posterior, popliteus, extensor digitorum longus) least affected. Muscle MRI showed EDB involvement that correlated with the patient's age (p = 0.055). We show a correlation between the MRI and EDB histopathologic changes, with MRI 3-4 grades associated with a more severe fibro-adipose tissue replacement. The EDB was sufficiently preserved for bulk and signal intensity in 18/22 wheelchair users aged 10-16.6 years. CONCLUSION This study provides a detailed correlation between muscle histology and MRI changes in DMD and demonstrates the value of this imaging technique as a reliable tool for the selection of muscles in patients recruited into clinical trials.
Collapse
|
118
|
Reza M, Laval S, Morgan J, Muntoni F, Bushby K, Straub V, Lochmüller H. P08 Optimal dystrophin mini-construct for gene delivery to skeletal muscle. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70027-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
119
|
Scoto M, Cirak S, Mein R, Feng L, Manzur A, Robb S, Childs AM, Quinlivan R, Roper H, Hilton-Jones D, Longman C, Chow G, Pane M, Main M, Hanna M, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F. P67 SEPN1 related myopathies: Clinical course in a large cohort of patients. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70086-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
120
|
Müller J, Senderek J, Dusl M, Guergueltcheva V, Laval S, Bushby K, Straub V, Beeson D, Abicht A, Lochmüller H. P26 Pyridostigmine-responsive limb-girdle congenital myasthenic syndrome with frequent tubular aggregates. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70045-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
121
|
Sarkozy A, Hicks P, Miller J, Walter M, Reilich P, Radunovic A, Vaidya S, Lochmüller H, Bushby K, Straub V. P75 Muscle MRI findings in LGMD2L. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70094-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
122
|
Wood A, Jepson C, Laval S, Bushby K, Lochmüller H, Barresi R, Müller J, Straub V. P19 Generating stable FKRP mutant zebrafish lines with zinc finger nucleases. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70038-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
123
|
Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Garralda M, Wells D, Dickson G, Wood M, Wilton S, Straub V, Shrewsbury S, Sewry C, Morgan J, Bushby K, Muntoni F. P03 Exon skipping and dystrophin restoration in Duchenne muscular dystrophy patients after systemic phosphorodiamidate morpholino oligomer treatment. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70022-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
124
|
Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M, Ertekin C, Ercan I, Solakoglu S, Karcagi V, Straub V, Bushby K, Lochmuller H, Serdaroglu-Oflazer P. Oculopharyngodistal myopathy is a distinct entity: Clinical and genetic features of 47 patients. Neurology 2011; 76:227-35. [DOI: 10.1212/wnl.0b013e318207b043] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
125
|
Quinlivan R, Shaw N, Bushby K. 170th ENMC International Workshop: Bone protection for corticosteroid treated Duchenne muscular dystrophy. 27–29 November 2009, Naarden, The Netherlands. Neuromuscul Disord 2010; 20:761-9. [DOI: 10.1016/j.nmd.2010.07.272] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2010] [Revised: 07/04/2010] [Accepted: 07/08/2010] [Indexed: 01/06/2023]
|